Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Kovai Medical Center & Hospital Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹5,980.50
High
₹6,189.00
Price Summary
| Previous Close | ₹6,015.00 |
|---|---|
| Day's Range | ₹5,980.50 - ₹6,189.00 |
| Open | ₹6,111.50 |
| 52 Week Range | ₹5,275.50 - ₹6,444.00 |
| Volume | 11,073 |
| Market Cap | ₹0.01 |
| Previous Close | ₹6,030.05 |
|---|---|
| Day's Range | ₹5,987.00 - ₹6,130.00 |
| Open | ₹6,050.40 |
| 52 Week Range | ₹5,010.00 - ₹6,725.00 |
| Volume | 2,922 |
| Market Cap | ₹0.01 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 666.04 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.24 |
| Price/Earning (TTM) | 117.08 |
| TTM EPS (₹) | 52.99 |
| P/E Ratio | 23.60 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 9.79 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 24.08 |
| Trade Value ( ₹ in Lacs) | 176.20 |
|---|---|
| Market Cap (₹ in Mn) | 0.01 |
| Dividend Yield(%) | 0.24 |
| Price/Earning (TTM) | 117.08 |
| TTM EPS (₹) | 52.99 |
| P/E Ratio | 23.60 |
| Book Value(₹) | 0.00 |
| PAT Margin (%) | 9.79 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 24.08 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 3739.28 | 13711.13 |
| Expenses | N/A | N/A |
| PBT | 763.83 | 2775.53 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 572.26 | 2089.46 |
About Kovai Medical Center & Hospital Ltd.
| Founded | 1985 |
|---|---|
| Managing Director | Nalla G Palaniswami |
| NSE Symbol | KOVAI |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,41,957.50 | 1,837.00 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,47,576.00 | 9,157.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,89,233.01 | 4,850.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,27,249.42 | 8,750.25 | 6,696.50 - 6,696.50 |
| Lenskart Solutions Ltd. | 1,18,577.20 | 686.55 | 0.00 - 0.00 |
| Zydus Lifesciences Ltd. | 1,11,670.55 | 1,103.00 | 835.50 - 835.50 |
| Cipla Ltd. | 1,10,272.68 | 1,349.15 | 1,165.70 - 1,165.70 |
| Laurus Labs Ltd. | 1,06,460.42 | 1,923.00 | 823.10 - 823.10 |
| Max Healthcare Institute Ltd. | 1,00,951.74 | 1,038.00 | 903.00 - 903.00 |
| Dr. Reddy's Laboratories Ltd. | 96,906.38 | 1,145.70 | 1,101.00 - 1,101.00 |
No Records Found
Latest News
Jul
9
2026
Posted on Jul 9th 2026
Kovai Medical Center and Hospital informs about confirmation certificate
Kovai Medical Center and Hospital has informed that it enclosed the Certificate received from its Registrar and Share Transfer Agent - GNSA Infotech, Chennai in compliance under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended 30th June, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
Jun
20
2026
Posted on Jun 20th 2026
Kovai Medical Center and Hospital informs about closure of trading window
Pursuant to Clause 4 of Schedule B of SEBI (Prohibition of Insider Trading) Regulations 2015, as amended and the Company's Code of Conduct for Prevention of Insider Trading, Kovai Medical Center and Hospital has informed that the Trading Window for trading in Company's Securities shall remain closed from 1st July 2026 till the end of 48 hours after the declaration of Un-audited Financial Results for the Quarter ended 30th June 2026 for insiders, designated persons and their immediate relatives. The date of Board Meeting for declaration of Un-audited Financial Results of the Company for the Quarter ended 30th June, 2026 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
15
2026
Posted on Sep 15th 2026
Boston Commerce informs about press release
Boston Commerce has informed that it enclosed Newspaper Clipping Advertisement published on 13th September, 2026 for Notice of the Annual General Meeting of the Company scheduled to be held on Wednesday, 30th September, 2026 at 5:00 P.M. (IST) through Video Conferencing Facility / Other Audio Visual Means (VC/OAVM) specifying therein the details pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, e-voting facility given by the Company pursuant to Section 108 of the Companies Act, 2013 and the Rules made thereunder. The Company has published an advertisement for which clipping of the Newspaper is attached and the same is also available on the website of the Company. This is in due compliance with the relevant Regulations of the SEBI (LODR) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
15
2026
Posted on Sep 15th 2026
Syschem India informs about trading window closure
Syschem India has informed that in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and SEBI (Prohibition of Insider Trading) (Amendment) Regulations, 2018, (PIT Regulations) and as per the Company's ‘Code of Conduct’, the trading window for dealing in the securities of the Company shall remain closed for Directors/officers/Designated Persons and their immediate relatives as defined under the PIT Regulations and the said code, from Thursday, 1 October, 2026 till the expiry of 48 (forty-eight) hours after the announcement of unaudited financial results of the company for the quarter ended on 30 September, 2026. The dates of the meeting of the Board of Directors of the Company, to approve the unaudited financial results of the Company for the quarter ended 30th September, 2026 will be intimated in due course.
The above information is a part of company’s filings submitted to BSE.
Read More
Sep
15
2026
Posted on Sep 15th 2026
AstraZeneca Pharma India informs about resignation of senior management personnel
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), AstraZeneca Pharma India has informed that Dr. Sandeep Arora, Director – Medical Affairs, Biopharmaceutical Business Unit and Rare Disease Business Unit, of the Company has decided to pursue a career outside the organization. Dr. Arora will complete his handover period and be relieved from duties by the close of business hours on September 15, 2026. The company has wished all the best for his future endeavors. A copy of the resignation letter is enclosed as Annexure – A. The Company is in the process of looking for a suitable replacement for this position. This being Senior Management Personnel position in terms of the SEBI Listing Regulations, it has enclosed the details as required under the SEBI Circular No. HO/49/14/14(7)2025 - CFD-POD2/I/3762/ 2026 dated January 30, 2026, attached as Annexure – B.
The above information is a part of company’s filings submitted to BSE.
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Kovai Medical Center & Hospital Ltd. is ₹6,015.00 as of 2026-09-15.
The market capitalisation of Kovai Medical Center & Hospital Ltd. is ₹6,788.36 as of 2026-09-11.
The 1-year return of Kovai Medical Center & Hospital Ltd. is % as of .
The P/E ratio of Kovai Medical Center & Hospital Ltd. is 22.48 as of 2026-09-15.
The 52-week high and low of Kovai Medical Center & Hospital Ltd. are ₹6,444.00 and ₹5,275.50, respectively, as of 2026-09-15.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
